Scientists investigate why some myeloma patients relapse after CART therapy
NCT ID NCT07180992
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 36 times
Summary
This study aims to understand why some people with multiple myeloma relapse early after CART cell therapy. Researchers will analyze specific immune cells called monocytes before and after treatment to see if they predict how well the therapy works. The study will involve 25 participants and is purely observational, meaning no new treatment is given.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU Amiens
RECRUITINGAmiens, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.